已收盘 03-27 16:00:00 美东时间
-0.625
-2.04%
Cadre Hldgs (NYSE:CDRE) released its Q4 earnings on Tuesday, March 10, 2026 at ...
03-11 05:30
Companies Reporting Before The Bell • Exagen (NASDAQ:XGN) is projected to repor...
2025-03-11 16:32
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
2024-09-20 20:46